Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Clementia Pharmaceuticals expands ongoing phase II study of palovarotene

Aug. 26, 2015

Researchers confirm brain-selectivity of estrogen prodrug, potential for menopause disorders

Aug. 25, 2015

Merck & Co. discloses FFAR1 agonists

Aug. 24, 2015

Apricus seeks partnering for Femprox in female sexual dysfunction

Aug. 21, 2015

Intarcia reports results from ITCA-650 phase III trial FREEDOM-2

Aug. 19, 2015

Lilly launches Humalog U-200 KwikPen in U.S.

Aug. 19, 2015

FDA approves first treatment for hypoactive sexual desire disorder in women

Aug. 19, 2015

Merck & Co. describes discovery of novel DGAT2 inhibitors

Aug. 19, 2015

FDA accepts NDA for dronabinol oral solution for CINV- and AIDS-associated anorexia

Aug. 18, 2015

FDA accepts NDA filing for octreotide

Aug. 18, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...